In 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) murine models of PD, TREM-2 deficiency results in reduced microglial activation and decreased expression of pro-inflammatory cytokines, albeit not affecting neuronal fate [83]. This evidence concerns the gene TREM2 and Parkinson disease.